ناشر تخصصی کنفرانس های ایران

لطفا کمی صبر نمایید

Publisher of Iranian Journals and Conference Proceedings

Please waite ..
Publisher of Iranian Journals and Conference Proceedings
Login |Register |Help |عضویت کتابخانه ها
Paper
Title

Design, synthesis and biological evaluation of sorafenib based compounds as potential anticancer agents using structure based approach

Year: 1400
COI: TETSCONF07_001
Language: EnglishView: 54
متن کامل این Paper منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل Paper (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

Buy and Download

متن کامل (فول تکست) این مقاله منتشر نشده و یا در سایت موجود نیست و امکان خرید آن فراهم نمی باشد.

Authors

Fereshteh Azimian - Department of Medicinal Chemistry, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
Maryam Hamzeh-Mivehroud - Department of Medicinal Chemistry, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
Javid Shahbazi Mojarrad - Department of Medicinal Chemistry, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran
Salar Hemmati - Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Siavoush Dastmalchi - Department of Medicinal Chemistry, School of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran

Abstract:

Angiogenesis as a critical step in the growth and metastasis of cancer is regulated by many growth factors such as the vascular endothelial growth factors (VEGFs) and receptor (VEGFR-۲). Developing novel inhibitors blocking VEGFR۲ and the Raf/MEK/ERK mitogen-activated protein kinase signaling pathway using in silico design approach is one of the research hotspot. To this goal, new compounds based on sorafenib were designed, synthesized and biologically evaluated. Using de novo design method, a library of new ligands was generated and expanded. Considering in silico binding affinity towards VEGFR۲, synthetic feasibility, and drug-likeness property, some of the designed ligands were selected for synthesis and screening for their in vitro anti-proliferative activities against two cancer cell lines (HT-۲۹ and A۵۴۹). Induction cell cycle arrest, induction apoptosis, ROS generation, VEGF۲ and Raf/MEK/ERK pathway phosphorylation blocking in HT-۲۹ cells upon exposure by the most active compound were evaluated. Molecular docking were used for prediction of binding mode of generated compounds towardsVEGFR۲ receptor. Collectively, in the current study in silico drug design, synthesise of novel compounds and biological evaluation conducted to get insight into identified new anticancer agents based on sorafenib related diarylurea compounds.

Keywords:

Lead optimization, de novo drug design, diaryl urea, synthesis, docking, antiproliferative activity

Paper COI Code

This Paper COI Code is TETSCONF07_001. Also You can use the following address to link to this article. This link is permanent and is used as an article registration confirmation in the Civilica reference:

https://civilica.com/doc/1231652/

How to Cite to This Paper:

If you want to refer to this Paper in your research work, you can simply use the following phrase in the resources section:
Azimian, Fereshteh and Hamzeh-Mivehroud, Maryam and Shahbazi Mojarrad, Javid and Hemmati, Salar and Dastmalchi, Siavoush,1400,Design, synthesis and biological evaluation of sorafenib based compounds as potential anticancer agents using structure based approach,7th International Conference on Innovative Technologies in Science, Engineering and Technology,https://civilica.com/doc/1231652

Research Info Management

Certificate | Report | من نویسنده این مقاله هستم

اطلاعات استنادی این Paper را به نرم افزارهای مدیریت اطلاعات علمی و استنادی ارسال نمایید و در تحقیقات خود از آن استفاده نمایید.

Scientometrics

The specifications of the publisher center of this Paper are as follows:
Type of center: علوم پزشکی
Paper count: 2,830
In the scientometrics section of CIVILICA, you can see the scientific ranking of the Iranian academic and research centers based on the statistics of indexed articles.

New Papers

Share this page

More information about COI

COI stands for "CIVILICA Object Identifier". COI is the unique code assigned to articles of Iranian conferences and journals when indexing on the CIVILICA citation database.

The COI is the national code of documents indexed in CIVILICA and is a unique and permanent code. it can always be cited and tracked and assumed as registration confirmation ID.

Support